Global solutions across the product lifecycle
Our teams and global biopharma professionals came together in Boston at BIO 2025, the gateway to the global life sciences community. Thank you to everyone who visited us at booth #2783! We shared how our strategic support and operational excellence extend across key areas, including:
- Research and development consulting
- Pharmacovigilance and risk management
- Regulatory, market access and HTA consulting
- Quality management and compliance
- Distribution and logistics
- Education and awareness
- Patient support
- Integrated commercialization services
- Channel strategy
- Efficient outsourcing models
Session recap
Super Session: Navigating Barriers on the Journey from Molecule to Marketplace: Strategies for Global Commercialization Success
On Tuesday, June 17th, Cencora experts hosted an engaging session exploring the commercial barriers biopharma companies face as they navigate their assets from molecule to marketplace.
In today’s dynamic landscape, where product types and therapies are diversifying, biopharma companies are seeking tailored commercial partnerships that address their unique needs—not a one-size-fits-all model. During the session, our experts discussed the interdependent challenges within the industry and shared actionable strategies to maximize capital use and drive commercial success.
In today’s dynamic landscape, where product types and therapies are diversifying, biopharma companies are seeking tailored commercial partnerships that address their unique needs—not a one-size-fits-all model. During the session, our experts discussed the interdependent challenges within the industry and shared actionable strategies to maximize capital use and drive commercial success.
Sandra Anderson
SVP, Commercialization, Cencora
Tom Doyle
Head, US Commercial Solutions, Cencora
Glenn Pauly
Former CCO, Alzheon
Alexander Natz
Secretary General, EUCOPE
Kelly Price
Managing Director of US Rare Disease, Esteve
General session recaps
General session
Breaking Through: Overcoming Early Development Challenges
On Monday, June 16th, attendees joined us for a compelling discussion on overcoming early development challenges in the biopharma space. This session highlighted key strategies to navigate the complexities of early-stage development and set the foundation for long-term success.
General session
From Clinical to Commercial: How Strategic Partnerships can Accelerate Development and Enable Launch Excellence
On Wednesday, June 18th, we explored how strategic partnerships can bridge the gap between clinical development and commercialization. This session offered valuable insights into how collaboration fosters accelerated development timelines and ensures launch excellence.
We are a part of BIO PartneringTM
We participated in the BIO Partnering system and had the opportunity to engage with many of you onsite at the convention. These conversations allowed us to better understand your goals and explore opportunities to support innovation and success in the biopharma space. We look forward to continuing these discussions and exploring potential paths forward.
